Lexis Nexis
 |    |  

Home > Search Legal Topics > Article Abstract



Another Federal District Court Rules That FDA Labeling Regulations Preempt Some State Law Tort Claims


by Gregory J. Wartman View Biography
Saul Ewing LLP View Firm Credentials
Philadelphia Office

April 10, 2008

Previously published on February 2008

A federal district court in Oklahoma recently ruled that a plaintiff's state law failure to warn claims against a prescription drug manufacturer are preempted by FDA regulations because FDA had considered and expressly rejected the plaintiff's proposed additional warning.


 

The views expressed in this article are solely the views of the author and not Martindale-Hubbell. This article is intended for informational purposes only and is not legal advice or a substitute for consultation with a licensed legal professional in a particular case or circumstance.




Total Practice Solutions

 
Terms & Conditions | Copyright 2008 LexisNexis, a division of Reed Elsevier Inc. All rights reserved.